Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 156

1.

Association of Systemic Inflammation With Retinal Vascular Caliber in Patients With AIDS.

Jabs DA, Van Natta ML, Trang G, Jones N, Milush JM, Cheu R, Klatt NR, Pak JW, Danis RP, Hunt PW.

Invest Ophthalmol Vis Sci. 2019 May 1;60(6):2218-2225. doi: 10.1167/iovs.18-26070.

2.

A Randomized Phase 2 Study of an Anti-Amyloid β Monoclonal Antibody in Geographic Atrophy Secondary to Age-Related Macular Degeneration.

Rosenfeld PJ, Berger B, Reichel E, Danis RP, Gress A, Ye L, Magee M, Parham LR, McLaughlin MM.

Ophthalmol Retina. 2018 Oct;2(10):1028-1040. doi: 10.1016/j.oret.2018.03.001. Epub 2018 Apr 17.

PMID:
31047490
3.

Relationship Between Opacity of Cytomegalovirus Retinitis Lesion Borders and Severity of Immunodeficiency Among People With AIDS.

Holland GN, Van Natta ML, Goldenberg DT, Ritts R Jr, Danis RP, Jabs DA; Studies of Ocular Complications of AIDS Research Group.

Invest Ophthalmol Vis Sci. 2019 May 1;60(6):1853-1862. doi: 10.1167/iovs.18-26517.

4.

Imaging Characteristics of Choroidal Neovascular Lesions in the AREDS2-HOME Study: Report Number 4.

Domalpally A, Clemons TE, Bressler SB, Danis RP, Elman M, Kim JE, Brown D, Chew EY.

Ophthalmol Retina. 2019 Apr;3(4):326-335. doi: 10.1016/j.oret.2019.01.004. Epub 2019 Jan 11.

PMID:
31014685
5.

Association of Age-related Macular Degeneration With Mortality in Patients With Acquired Immunodeficiency Syndrome; Role of Systemic Inflammation.

Jabs DA, Van Natta ML, Trang G, Jones NG, Milush JM, Cheu R, Klatt NR, Danis RP, Hunt PW.

Am J Ophthalmol. 2019 Mar;199:230-237. doi: 10.1016/j.ajo.2018.12.002. Epub 2018 Dec 12.

PMID:
30552890
6.

Atrophy in Neovascular Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report Number 15.

Domalpally A, Danis RP, Trane R, Blodi BA, Clemons TE, Chew EY; Age-Related Eye Disease Study 2 (AREDS2) Research Group.

Ophthalmol Retina. 2018 Oct;2(10):1021-1027. doi: 10.1016/j.oret.2018.04.009. Epub 2018 Jun 2.

7.

CHANGES IN DIABETIC RETINOPATHY SEVERITY WHEN TREATING DIABETIC MACULAR EDEMA WITH RANIBIZUMAB: DRCR.net Protocol I 5-Year Report.

Bressler SB, Odia I, Glassman AR, Danis RP, Grover S, Hampton GR, Jampol LM, Maguire MG, Melia M.

Retina. 2018 Oct;38(10):1896-1904. doi: 10.1097/IAE.0000000000002302.

8.

Treatment of Geographic Atrophy with Intravitreal Sirolimus: The Age-Related Eye Disease Study 2 Ancillary Study.

Gensler G, Clemons TE, Domalpally A, Danis RP, Blodi B, Wells J 3rd, Rauser M, Hoskins J, Hubbard GB, Elman MJ, Fish GE, Brucker A, Margherio A, Chew EY.

Ophthalmol Retina. 2018 May;2(5):441-450. doi: 10.1016/j.oret.2017.08.015.

9.

Reply.

Willoughby AS, Vuong VS, Cunefare D, Farsiu S, Noronha G, Danis RP, Yiu G.

Am J Ophthalmol. 2018 May;189:178. doi: 10.1016/j.ajo.2018.03.002. Epub 2018 Mar 22. No abstract available.

PMID:
29576184
10.

Association of Retinal Vascular Caliber and Age-Related Macular Degeneration in Patients With the Acquired Immunodeficiency Syndrome.

Jabs DA, Van Natta ML, Pak JW, Danis RP, Hunt PW.

Invest Ophthalmol Vis Sci. 2018 Feb 1;59(2):904-908. doi: 10.1167/iovs.17-23334.

11.

Lack of Longitudinal Association Between Thiazolidinediones and Incidence and Progression of Diabetic Eye Disease: The ACCORD Eye Study.

Gower EW, Lovato JF, Ambrosius WT, Chew EY, Danis RP, Davis MD, Goff DC Jr, Greven CM; ACCORD Study Group.

Am J Ophthalmol. 2018 Mar;187:138-147. doi: 10.1016/j.ajo.2017.12.007. Epub 2017 Dec 22.

12.

Choroidal Changes After Suprachoroidal Injection of Triamcinolone Acetonide in Eyes With Macular Edema Secondary to Retinal Vein Occlusion.

Willoughby AS, Vuong VS, Cunefare D, Farsiu S, Noronha G, Danis RP, Yiu G.

Am J Ophthalmol. 2018 Feb;186:144-151. doi: 10.1016/j.ajo.2017.11.020. Epub 2017 Dec 2.

13.

Consensus Definition for Atrophy Associated with Age-Related Macular Degeneration on OCT: Classification of Atrophy Report 3.

Sadda SR, Guymer R, Holz FG, Schmitz-Valckenberg S, Curcio CA, Bird AC, Blodi BA, Bottoni F, Chakravarthy U, Chew EY, Csaky K, Danis RP, Fleckenstein M, Freund KB, Grunwald J, Hoyng CB, Jaffe GJ, Liakopoulos S, Monés JM, Pauleikhoff D, Rosenfeld PJ, Sarraf D, Spaide RF, Tadayoni R, Tufail A, Wolf S, Staurenghi G.

Ophthalmology. 2018 Apr;125(4):537-548. doi: 10.1016/j.ophtha.2017.09.028. Epub 2017 Nov 2. Erratum in: Ophthalmology. 2019 Jan;126(1):177.

PMID:
29103793
14.

Incidence of Intermediate-stage Age-related Macular Degeneration in Patients With Acquired Immunodeficiency Syndrome.

Jabs DA, Van Natta ML, Pak JW, Danis RP, Hunt PW.

Am J Ophthalmol. 2017 Jul;179:151-158. doi: 10.1016/j.ajo.2017.05.004. Epub 2017 May 10.

15.

Peripheral Retinal Changes Associated with Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report Number 12 by the Age-Related Eye Disease Study 2 Optos PEripheral RetinA (OPERA) Study Research Group.

Writing Committee for the OPTOS PEripheral RetinA (OPERA) study (Ancillary Study of Age-Related Eye Disease Study 2), Domalpally A, Clemons TE, Danis RP, Sadda SR, Cukras CA, Toth CA, Friberg TR, Chew EY.

Ophthalmology. 2017 Apr;124(4):479-487. doi: 10.1016/j.ophtha.2016.12.004. Epub 2017 Jan 12.

PMID:
28089680
16.

Evaluating the Validity of the Age-Related Eye Disease Study Grading Scale for Age-Related Macular Degeneration: AREDS2 Report 10.

Vitale S, Clemons TE, Agrón E, Ferris FL 3rd, Domalpally A, Danis RP, Chew EY; Age-Related Eye Disease Study 2 (AREDS2) Research Group.

JAMA Ophthalmol. 2016 Sep 1;134(9):1041-7. doi: 10.1001/jamaophthalmol.2016.2383.

PMID:
27442263
17.

Quantitative Assessment of Optic Nerve Changes in Patients With Diabetic Macular Edema Treated With Fluocinolone Acetonide Vitreous Implants.

Parrish RK 2nd, Traverso CE, Green K, Danis RP; FAME Study Group.

Ophthalmic Surg Lasers Imaging Retina. 2016 May 1;47(5):418-25. doi: 10.3928/23258160-20160419-04.

PMID:
27183545
18.

Variability in Spectral-Domain Optical Coherence Tomography over 4 Weeks by Age.

Howard KP, Chandler CS, Huang Y, Klein BE, Lee KE, Meuer SM, Danis RP, Danforth LG, Gangnon RE, Klein R.

Ophthalmic Epidemiol. 2016 Jun;23(3):193-201. doi: 10.3109/09286586.2015.1119285. Epub 2016 Apr 29.

19.

Relationship of retinal vascular calibre and diabetic retinopathy in Chinese patients with type 2 diabetes mellitus: the Desheng Diabetic Eye Study.

Yang X, Deng Y, Gu H, Ren X, Lim A, Snellingen T, Liu X, Wang N, Won Pak J, Liu N, Danis RP.

Br J Ophthalmol. 2016 Oct;100(10):1359-65. doi: 10.1136/bjophthalmol-2014-306078. Epub 2016 Jan 28.

PMID:
26823397
20.

RELATIONSHIP BETWEEN RETINAL THICKNESS AND VISUAL ACUITY IN EYES WITH RETINAL VEIN OCCLUSION TREATED WITH DEXAMETHASONE IMPLANT.

Danis RP, Sadda S, Jiao J, Li XY, Whitcup SM.

Retina. 2016 Jun;36(6):1170-6. doi: 10.1097/IAE.0000000000000851.

PMID:
26655606
21.

Geographic atrophy in patients with advanced dry age-related macular degeneration: current challenges and future prospects.

Danis RP, Lavine JA, Domalpally A.

Clin Ophthalmol. 2015 Nov 20;9:2159-74. doi: 10.2147/OPTH.S92359. eCollection 2015. Review.

22.

Anatomical effects of dexamethasone intravitreal implant in diabetic macular oedema: a pooled analysis of 3-year phase III trials.

Danis RP, Sadda S, Li XY, Cui H, Hashad Y, Whitcup SM.

Br J Ophthalmol. 2016 Jun;100(6):796-801. doi: 10.1136/bjophthalmol-2015-306823. Epub 2015 Nov 18.

23.

Quality Control Measures over 30 Years in a Multicenter Clinical Study: Results from the Diabetes Control and Complications Trial / Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study.

Lorenzi GM, Braffett BH, Arends VL, Danis RP, Diminick L, Klumpp KA, Morrison AD, Soliman EZ, Steffes MW, Cleary PA; DCCT/EDIC Research Group.

PLoS One. 2015 Nov 3;10(11):e0141286. doi: 10.1371/journal.pone.0141286. eCollection 2015.

24.

Darapladib, a lipoprotein-associated phospholipase A2 inhibitor, in diabetic macular edema: a 3-month placebo-controlled study.

Staurenghi G, Ye L, Magee MH, Danis RP, Wurzelmann J, Adamson P, McLaughlin MM; Darapladib DME Study Group.

Ophthalmology. 2015 May;122(5):990-6. doi: 10.1016/j.ophtha.2014.12.014. Epub 2015 Mar 5.

PMID:
25749297
25.

The epidemiology of vitreoretinal interface abnormalities as detected by spectral-domain optical coherence tomography: the beaver dam eye study.

Meuer SM, Myers CE, Klein BE, Swift MK, Huang Y, Gangaputra S, Pak JW, Danis RP, Klein R.

Ophthalmology. 2015 Apr;122(4):787-95. doi: 10.1016/j.ophtha.2014.10.014. Epub 2014 Dec 31.

26.

Retinal thickness measured by spectral-domain optical coherence tomography in eyes without retinal abnormalities: the Beaver Dam Eye Study.

Myers CE, Klein BE, Meuer SM, Swift MK, Chandler CS, Huang Y, Gangaputra S, Pak JW, Danis RP, Klein R.

Am J Ophthalmol. 2015 Mar;159(3):445-56.e1. doi: 10.1016/j.ajo.2014.11.025. Epub 2014 Nov 25.

27.

Clinical evaluation of pazopanib eye drops versus ranibizumab intravitreal injections in subjects with neovascular age-related macular degeneration.

Csaky KG, Dugel PU, Pierce AJ, Fries MA, Kelly DS, Danis RP, Wurzelmann JI, Xu CF, Hossain M, Trivedi T.

Ophthalmology. 2015 Mar;122(3):579-88. doi: 10.1016/j.ophtha.2014.09.036. Epub 2014 Nov 26.

PMID:
25432081
28.

Response to aflibercept in patients with persistent exudation despite prior treatment with bevacizumab or ranibizumab for age-related macular degeneration.

Eadie JA, Gottlieb JL, Ip MS, Blodi BA, Danis RP, Chandra SR, Nork TM, Altaweel MM, Stern-Hogan BS.

Ophthalmic Surg Lasers Imaging Retina. 2014 Sep-Oct;45(5):394-7.

PMID:
25230402
29.

The cross-sectional and longitudinal associations of diabetic retinopathy with cognitive function and brain MRI findings: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.

Hugenschmidt CE, Lovato JF, Ambrosius WT, Bryan RN, Gerstein HC, Horowitz KR, Launer LJ, Lazar RM, Murray AM, Chew EY, Danis RP, Williamson JD, Miller ME, Ding J.

Diabetes Care. 2014 Dec;37(12):3244-52. doi: 10.2337/dc14-0502. Epub 2014 Sep 5.

30.

The effects of medical management on the progression of diabetic retinopathy in persons with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Eye Study.

Chew EY, Davis MD, Danis RP, Lovato JF, Perdue LH, Greven C, Genuth S, Goff DC, Leiter LA, Ismail-Beigi F, Ambrosius WT; Action to Control Cardiovascular Risk in Diabetes Eye Study Research Group.

Ophthalmology. 2014 Dec;121(12):2443-51. doi: 10.1016/j.ophtha.2014.07.019. Epub 2014 Aug 29.

31.

Application of random forests methods to diabetic retinopathy classification analyses.

Casanova R, Saldana S, Chew EY, Danis RP, Greven CM, Ambrosius WT.

PLoS One. 2014 Jun 18;9(6):e98587. doi: 10.1371/journal.pone.0098587. eCollection 2014.

32.

Sustained delivery fluocinolone acetonide vitreous implants: long-term benefit in patients with chronic diabetic macular edema.

Cunha-Vaz J, Ashton P, Iezzi R, Campochiaro P, Dugel PU, Holz FG, Weber M, Danis RP, Kuppermann BD, Bailey C, Billman K, Kapik B, Kane F, Green K; FAME Study Group.

Ophthalmology. 2014 Oct;121(10):1892-903. doi: 10.1016/j.ophtha.2014.04.019. Epub 2014 Jun 14.

33.

Randomized trial of the ForeseeHome monitoring device for early detection of neovascular age-related macular degeneration. The HOme Monitoring of the Eye (HOME) study design - HOME Study report number 1.

Chew EY, Clemons TE, Bressler SB, Elman MJ, Danis RP, Domalpally A, Heier JS, Kim JE, Garfinkel RA; Appendix 1 for AREDS2-HOME Study Research Group.

Contemp Clin Trials. 2014 Mar;37(2):294-300. doi: 10.1016/j.cct.2014.02.003. Epub 2014 Feb 13.

PMID:
24530651
34.

Development of a semi-automatic segmentation method for retinal OCT images tested in patients with diabetic macular edema.

Huang Y, Danis RP, Pak JW, Luo S, White J, Zhang X, Narkar A, Domalpally A.

PLoS One. 2013 Dec 26;8(12):e82922. doi: 10.1371/journal.pone.0082922. eCollection 2013.

35.

Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3.

Age-Related Eye Disease Study 2 (AREDS2) Research Group, Chew EY, Clemons TE, Sangiovanni JP, Danis RP, Ferris FL 3rd, Elman MJ, Antoszyk AN, Ruby AJ, Orth D, Bressler SB, Fish GE, Hubbard GB, Klein ML, Chandra SR, Blodi BA, Domalpally A, Friberg T, Wong WT, Rosenfeld PJ, Agrón E, Toth CA, Bernstein PS, Sperduto RD.

JAMA Ophthalmol. 2014 Feb;132(2):142-9. doi: 10.1001/jamaophthalmol.2013.7376.

36.

Randomized trial of a home monitoring system for early detection of choroidal neovascularization home monitoring of the Eye (HOME) study.

AREDS2-HOME Study Research Group, Chew EY, Clemons TE, Bressler SB, Elman MJ, Danis RP, Domalpally A, Heier JS, Kim JE, Garfinkel R.

Ophthalmology. 2014 Feb;121(2):535-44. doi: 10.1016/j.ophtha.2013.10.027. Epub 2013 Nov 8.

37.

Circularity index as a risk factor for progression of geographic atrophy.

Domalpally A, Danis RP, White J, Narkar A, Clemons T, Ferris F, Chew E.

Ophthalmology. 2013 Dec;120(12):2666-2671. doi: 10.1016/j.ophtha.2013.07.047. Epub 2013 Oct 24.

PMID:
24206616
38.

Retinal vascular abnormalities in neovascular age-related macular degeneration.

Jackson TL, Danis RP, Goldbaum M, Slakter JS, Shusterman EM, OʼShaughnessy DJ, Moshfeghi DM.

Retina. 2014 Mar;34(3):568-75. doi: 10.1097/IAE.0b013e3182a487be.

PMID:
24045343
39.

Validity of self-report in type 1 diabetic subjects for laser treatment of retinopathy.

Grassi MA, Sun W, Gangaputra S, Cleary PA, Hubbard L, Lachin JM, Gao X, Kiss S, Barkmeier AJ, Almony A, Davis M, Klein R, Danis RP; DCCT/EDIC Research Group.

Ophthalmology. 2013 Dec;120(12):2580-2586. doi: 10.1016/j.ophtha.2013.06.002. Epub 2013 Jul 24.

40.

Evaluation of optimized digital fundus reflex photographs for lens opacities in the age-related eye disease study 2: AREDS2 report 7.

Domalpally A, Danis RP, Chew EY, Clemons TE, Reed S, Sangiovanni JP, Ferris FL 3rd; Age-Related Eye Disease Study 2 Research Group.

Invest Ophthalmol Vis Sci. 2013 Sep 5;54(9):5989-94. doi: 10.1167/iovs.13-12301.

41.

Correlates of hypertension in patients with AIDS in the era of highly active antiretroviral therapy.

Krauskopf K, Van Natta ML, Danis RP, Gangaputra S, Ackatz L, Addessi A, Federman AD, Branch AD, Meinert CL, Jabs DA; Studies of the Ocular Complications of AIDS Research Group.

J Int Assoc Provid AIDS Care. 2013 Sep-Oct;12(5):325-33.

42.

Effect of optical coherence tomography scan decentration on macular center subfield thickness measurements.

Pak JW, Narkar A, Gangaputra S, Klein R, Klein B, Meuer S, Huang Y, Danis RP.

Invest Ophthalmol Vis Sci. 2013 Jul 2;54(7):4512-8. doi: 10.1167/iovs.13-12265.

43.

Methods and reproducibility of grading optimized digital color fundus photographs in the Age-Related Eye Disease Study 2 (AREDS2 Report Number 2).

Danis RP, Domalpally A, Chew EY, Clemons TE, Armstrong J, SanGiovanni JP, Ferris FL 3rd; AREDS2 Study Group.

Invest Ophthalmol Vis Sci. 2013 Jul 8;54(7):4548-54. doi: 10.1167/iovs.13-11804.

44.

Comparison of standardized clinical classification with fundus photograph grading for the assessment of diabetic retinopathy and diabetic macular edema severity.

Gangaputra S, Lovato JF, Hubbard L, Davis MD, Esser BA, Ambrosius WT, Chew EY, Greven C, Perdue LH, Wong WT, Condren A, Wilkinson CP, Agrón E, Adler S, Danis RP; ACCORD Eye Research Group.

Retina. 2013 Jul-Aug;33(7):1393-9. doi: 10.1097/IAE.0b013e318286c952.

45.

Vascular changes in eyes treated with dexamethasone intravitreal implant for macular edema after retinal vein occlusion.

Sadda S, Danis RP, Pappuru RR, Keane PA, Jiao J, Li XY, Whitcup SM.

Ophthalmology. 2013 Jul;120(7):1423-31. doi: 10.1016/j.ophtha.2012.12.021. Epub 2013 Mar 15.

PMID:
23499064
46.

Effect of image compression and resolution on retinal vascular caliber.

Pauli TW, Gangaputra S, Hubbard LD, Thayer DW, Chandler CS, Peng Q, Narkar A, Ferrier NJ, Danis RP.

Invest Ophthalmol Vis Sci. 2012 Aug 1;53(9):5117-23. doi: 10.1167/iovs.12-9643.

PMID:
22736618
47.

Signal quality assessment of retinal optical coherence tomography images.

Huang Y, Gangaputra S, Lee KE, Narkar AR, Klein R, Klein BE, Meuer SM, Danis RP.

Invest Ophthalmol Vis Sci. 2012 Apr 24;53(4):2133-41. doi: 10.1167/iovs.11-8755.

48.

Incidence of cytomegalovirus retinitis in the era of highly active antiretroviral therapy.

Sugar EA, Jabs DA, Ahuja A, Thorne JE, Danis RP, Meinert CL; Studies of the Ocular Complications of AIDS Research Group.

Am J Ophthalmol. 2012 Jun;153(6):1016-24.e5. doi: 10.1016/j.ajo.2011.11.014. Epub 2012 Feb 4.

49.

Automated assessment of drusen using three-dimensional spectral-domain optical coherence tomography.

Iwama D, Hangai M, Ooto S, Sakamoto A, Nakanishi H, Fujimura T, Domalpally A, Danis RP, Yoshimura N.

Invest Ophthalmol Vis Sci. 2012 Mar 21;53(3):1576-83. doi: 10.1167/iovs.11-8103.

PMID:
22297491
50.

Proportionate topographic areas of retinal zones 1, 2, and 3 for use in describing infectious retinitis.

Cunningham ET Jr, Hubbard LD, Danis RP, Holland GN.

Arch Ophthalmol. 2011 Nov;129(11):1507-8. doi: 10.1001/archophthalmol.2011.331. No abstract available.

Supplemental Content

Loading ...
Support Center